PT ES Get the brief

Schwannoma Intelligence Hub

Navigating Schwannoma,
Together.

The most common cranial nerve tumor, schwannomas affect approximately 1 in 100,000 people annually. This platform was built to make clinical trial information accessible to every patient and caregiver.

Read the Schwannoma Guide Explore the research

Free forever · Written for patients & families · No medical jargon

Live research field · updated hourly

157Studies tracked

2,500Sources monitored

24/7Live analysis

ClinicalTrials.gov, PubMed, the FDA and thousands of medical sources — read continuously, scored for Schwannoma relevance.

Where would you like to start?

Everything you need, in one place

Tools and information for everyone navigating Schwannoma — from a clear diagnosis guide to the very latest research.

Understanding Schwannoma

A clear guide to schwannomas, treatments, and what to expect.

Read the Schwannoma Guide

Research & publications

Curated trials, molecular data, and research trends for schwannoma.

Browse publications

Clinical trials

Explore active trials by condition, location, and treatment type.

Search trials

Continuously classified · relevance-scored

How we work

How we keep you informed

We read thousands of global medical sources around the clock, analyse new studies as they emerge, and translate the complex ones into clear, everyday language — so what matters reaches you without the noise.

We monitor

Continuously scanning ClinicalTrials.gov, PubMed, the FDA and thousands of sources for new Schwannoma-relevant research.

We analyse

Every study is classified, scored for relevance, and enriched with molecular markers and treatment data.

You discover

Browse an intelligence dashboard, explore active trials, or read a curated brief — all in clear, everyday language.

Why Zyntha

The information exists.
Now it’s yours.

We use technology to accelerate clinical trials efficiently, bring new treatments to patients faster, and work toward improving outcomes for every schwannoma patient.

Built specifically for the Schwannoma community — every study written for patients and families, updated within hours.

Why this platform

What makes this different

Written without the jargon

Every study, trial, and article is summarised so patients and families can actually understand it.

Updated continuously

Running 24/7 across thousands of sources. New trials and publications appear within hours — not weeks.

Designed for Schwannoma

Built for one community. Every feature — from molecular markers to subtype filters — speaks your language.

Trusted sources

Sourced from the world’s leading institutions

All content comes from peer-reviewed journals, verified trial registries, and top cancer research centres.

ClinicalTrials.govPubMedThe Lancet OncologyNature MedicineFDANCINeuro-OncologyASCOMD AndersonDana-FarberMemorial Sloan KetteringJAMA +108 more

Every article is scored for schwannoma relevance, classified by WHO grading criteria, and summarized in patient-friendly language before it reaches you.

We are not medical professionals. This platform is for educational and research purposes only — always consult your healthcare team for treatment decisions.

Navigating Schwannoma,Together.